What is the appropriate treatment for a non‑pregnant female with urinary symptoms who tests positive for Group B Streptococcus (Streptococcus agalactiae) and Ureaplasma?

Treatment for Group B Streptococcus and Ureaplasma in Non-Pregnant Female with Urinary Symptoms

Treat the Group B Streptococcus UTI with ampicillin or amoxicillin as first-line therapy, and separately treat the Ureaplasma with doxycycline if clinically indicated based on persistent symptoms after GBS treatment.

Primary Treatment Approach

For Group B Streptococcus (GBS)

GBS is a legitimate urinary pathogen in non-pregnant adults and requires treatment when causing symptomatic UTI 1, 2. The evidence shows:

• Ampicillin or amoxicillin are the antibiotics of choice for GBS urinary tract infections 1, 3
• All GBS isolates demonstrate universal susceptibility to penicillin, ampicillin, amoxicillin, and vancomycin 4, 3
• Oral ampicillin treatment has proven successful in clinical practice 1

Key consideration: GBS bacteriuria in non-pregnant adults signals the need to screen for underlying urinary tract abnormalities, as 60% of patients have structural abnormalities and 27% have chronic renal failure 2. You should evaluate for:

• Urinary tract anatomic abnormalities
• Diabetes mellitus (present in 80% of hospitalized cases) 3
• Chronic renal failure
• Immunocompromising conditions 4

For Ureaplasma

The treatment decision for Ureaplasma is more nuanced:

• Ureaplasma parvum accounts for 92.6% of genital Ureaplasma isolates and is found in both symptomatic (79.5%) and asymptomatic (20.5%) women 5
• Doxycycline is the first-line antibiotic with 100% susceptibility, along with josamycin, erythromycin, tetracycline, clarithromycin, and pristinamycin 5
• Quinolones (ofloxacin, ciprofloxacin) show poor activity and should be avoided 5

Critical caveat: Ureaplasma colonization is extremely common in reproductive-age women and does not always represent pathogenic infection. The 2024 EAU guidelines emphasize that asymptomatic bacteriuria should NOT be treated in non-pregnant women without risk factors 6.

Treatment Algorithm

1. Initiate treatment for symptomatic GBS UTI immediately:

   • Ampicillin 500 mg PO TID for 5-7 days, OR
   • Amoxicillin 500 mg PO TID for 5-7 days
   • Alternative for penicillin allergy: Vancomycin (though oral bioavailability is poor for systemic infections)

2. Assess response after GBS treatment:

   • If symptoms resolve completely → No additional treatment needed for Ureaplasma
   • If urinary symptoms persist after adequate GBS treatment → Consider Ureaplasma as pathogenic

3. If treating Ureaplasma (only if symptomatic after GBS treatment):

   • Doxycycline 100 mg PO BID for 7 days
   • Alternative: Azithromycin 1g single dose (though susceptibility data favors doxycycline)

4. Screen for underlying conditions:

   • Obtain imaging to exclude urinary tract abnormalities, especially if urease-producing organisms present 6
   • Check for diabetes mellitus
   • Evaluate renal function

Important Clinical Pitfalls

• Do not treat Ureaplasma as asymptomatic bacteriuria: The guideline evidence strongly recommends against treating asymptomatic bacteriuria in non-pregnant women 6. Ureaplasma is frequently a commensal organism.

• Avoid fluoroquinolones for Ureaplasma: Only 42.9% susceptibility to ofloxacin and 24.5% to ciprofloxacin makes quinolones inappropriate 5

• Do not ignore the GBS finding: Unlike Ureaplasma, symptomatic GBS bacteriuria represents true infection requiring treatment and warrants investigation for underlying urological abnormalities 2

• Erythromycin resistance in GBS is emerging: 25-36% of GBS strains show erythromycin resistance 4, 3, making macrolides less reliable for GBS despite their effectiveness against Ureaplasma

• Post-treatment cultures are not routinely indicated if the patient becomes asymptomatic 6